diabetestalk.net

Euglycemic Ketoacidosis Mechanism

Share on facebook

Euglycemic Diabetic Ketoacidosis: A Potential Complication Of Treatment With Sodiumglucose Cotransporter 2 Inhibition

Objective Sodiumglucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complication. Research Design and Methods Cases identified incidentally are described. Results We identified 13 episodes of SGLT-2 inhibitorassociated euDKA or ketosis in nine individuals, seven with type 1 diabetes and two with type 2 diabetes, from various practices across the U.S. The absence of significant hyperglycemia in these patients delayed recognition of the emergent nature of the problem by patients and providers. Conclusions SGLT-2 inhibitors seem to be associated with euglycemic DKA and ketosis, perhaps as a consequence of their noninsulin-dependent glucose clearance, hyperglucagonemia, and volume depletion. Patients with type 1 or type 2 diabetes who experience nausea, vomiting, or malaise or develop a metabolic acidosis in the setting of SGLT-2 inhibitor therapy should be promptly evaluated for the presence of urine and/or serum ketones. SGLT-2 inhibitors should only be used with grea Continue reading >>

Share on facebook

Popular Questions

  1. Fwatuheard

    Sorry if this question has been asked a million times, but the search didn't get me what I was looking for.
    I've been on a TKD for 2 days now, and I'm not quite sure if I'm doing all of this correctly. I can't really monitor my diet down to the calorie due to my job, but I'm using common knowledge to steer clear of carbs (bread, rice, beans, fruit, etc, etc). I'm estimating that I've been consuming around 40-50 carbs a day with the bulk of it coming from my post-workout shake.
    From you keto pros out there, do you think I can achieve ketosis with my current carb intake, or should I restrict carbs even further? I'm starting to feel like I should restrict carbs totally save for my carb up day at the end of the week ala the CKD.
    All I all I got the basics down, but I think I need a little more guidance. Any help would be much appreciated.

  2. timmymayes

    I was into ketosis within 3 days...but i did a 3 day fast to get into it. I think it can take up to 10 days depending....I think thats the duration of induction on atkins.

  3. �STFU!ˇN�LIFT!

    how the HELL do you not eat for 3 days ?
    one day even omg

  4. -> Continue reading
read more
Share on facebook

DKA diabetic ketoacidosis nursing management pathophysiology & treatment. DKA is a complication of diabetes mellitus and mainly affects type 1 diabetics. DKA management includes controlling hyperglycemia, ketosis, and acdidosis. Signs & Symptoms include polyuria, polydipsia, hyperglycemia greater than 300 mg/dL, Kussmaul breathing, acetone breath, and ketones in the urine. Typically DKA treatment includes: intravenous fluids, insulin therapy (IV regular insulin), and electrolyte replacement. This video details what the nurse needs to know for the NCLEX exam about diabetic ketoacidosis. I also touch on DKA vs HHS (diabetic ketoacidosis and hyperosmolar hyperglycemic nonketotic syndrome (please see the other video for more details). Quiz on DKA: http://www.registerednursern.com/diab... Lecture Notes for this video: http://www.registerednursern.com/diab... Diabetes NCLEX Review Videos: https://www.youtube.com/playlist?list... Subscribe: http://www.youtube.com/subscription_c... Nursing School Supplies: http://www.registerednursern.com/the-... Nursing Job Search: http://www.registerednursern.com/nurs... Visit our website RegisteredNurseRN.com for free quizzes, nursing care plans, salary information, job search, and much more: http://www.registerednursern.com Check out other Videos: https://www.youtube.com/user/Register... Popular Playlists: "NCLEX Study Strategies": https://www.youtube.com/playlist?list... "Fluid & Electrolytes Made So Easy": https://www.youtube.com/playlist?list... "Nursing Skills Videos": https://www.youtube.com/playlist?list... "Nursing School Study Tips": https://www.youtube.com/playlist?list... "Nursing School Tips & Questions": https://www.youtube.com/playlist?list... "Teaching Tutorials": https://www.youtube.com/playlist?list... "Types of Nursing Specialties": https://www.youtube.com/playlist?list... "Healthcare Salary Information": https://www.youtube.com/playlist?list... "New Nurse Tips": https://www.youtube.com/playlist?list... "Nursing Career Help": https://www.youtube.com/playlist?list... "EKG Teaching Tutorials": https://www.youtube.com/playlist?list... "Personality Types": https://www.youtube.com/playlist?list... "Dosage & Calculations for Nurses": https://www.youtube.com/playlist?list... "Diabetes Health Managment": https://www.youtube.com/playlist?list...

Dka That Wasn't: A Case Of Euglycemic Diabetic Ketoacidosis Due To Empagliflozin | Oxford Medical Case Reports | Oxford Academic

Sodium glucose co-transporter (SGLT-2) inhibitor is a relatively new medication used to treat diabetes. At present, the Food and Drug Administration (FDA) has only approved three medications (canagliflozin, dapagliflozin and empagliflozin) in this drug class for the management of Type 2 diabetes. In May 2015, the FDA issued a warning of ketoacidosis with use of this drug class. Risk factors for the development of ketoacidosis among patients who take SGLT-2 inhibitors include decrease carbohydrate intake/starvation, acute illness and decrease in insulin dose. When identified, immediate cessation of the medication and administration of glucose must be done, and in some instances, starting an insulin drip might be necessary. We present a case of a patient with diabetes mellitus being on empagliflozin (SGLT-2 antagonist) who was admitted for acute cholecystitis. The hospital course was complicated by euglycemic diabetic ketoacidosis after being kept nothing per orem before a contemplated cholecystectomy. The management of diabetes has evolved since its discovery in 1910. A gamut of medications has become available to address the glycemic control among diabetics especially for Type 2 d Continue reading >>

Share on facebook

Popular Questions

  1. [deleted]

    Thanks for the info. Thats one of my biggest fears is getting those fuckers.

  2. L15t3r0f5m3g

    It should be. I've had them twice. You don't want them.

  3. moose_testes

    Had them once. I'd probably give up a testicle if it meant never having them again. Fucking hell they were.

  4. -> Continue reading
read more
Share on facebook

Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor Inhibitors of sodiumglucose cotransporter 2 (SGLT2) decrease plasma glucose by blocking the reabsorption of glucose at the proximal tubule.1,2 Case reports have suggested that SGLT2 inhibitors may be associated with an increased risk of diabetic ketoacidosis, which led to a warning from the Food and Drug Administration (FDA) in May 2015.3,4 The objective of our study was to assess the risk of diabetic ketoacidosis after the initiation of an SGLT2 inhibitor. https://www.youtube.com/channel/UCsqm...

Risk Of Diabetic Ketoacidosis After Initiation Of An Sglt2 Inhibitor

To the Editor: Inhibitors of sodium–glucose cotransporter 2 (SGLT2) decrease plasma glucose by blocking the reabsorption of glucose at the proximal tubule.1,2 Case reports have suggested that SGLT2 inhibitors may be associated with an increased risk of diabetic ketoacidosis, which led to a warning from the Food and Drug Administration (FDA) in May 2015.3,4 The objective of our study was to assess the risk of diabetic ketoacidosis after the initiation of an SGLT2 inhibitor. Using a large claims database of commercially insured patients in the United States (Truven MarketScan), we identified a cohort of adult patients (≥18 years of age) who had newly started treatment with either an SGLT2 inhibitor or a dipeptidyl peptidase-4 (DPP4) inhibitor between April 1, 2013, and December 31, 2014 (before the FDA warning). DPP4 inhibitors were chosen as the comparator medication because they are similarly used as a second-line treatment for diabetes but have no known association with diabetic ketoacidosis. We excluded patients with human immunodeficiency virus infection, end-stage renal disease, cancer, type 1 diabetes, or past diabetic ketoacidosis. Our primary outcome was hospitalization Continue reading >>

Share on facebook

Popular Questions

  1. Jaxsurf

    Post your tricks for inducing Ketosis QUICK!!!

    Having a tough time getting into keto, how do you all get into keto fast!?

  2. RonJ73

    From what I've been reading on it, it's almost like the higher the fat in the first day, the quicker you'll get into it. Some people suggested like 50-60 (or even more) percent of your calories coming from fat and as little carbs as possible. Like down to 15%.

  3. Skumster225

    Try to eat anywhere from 0-20 carbs the first 2 days and up your fat intake. You should be in ketosis by then..

  4. -> Continue reading
read more

No more pages to load

Related Articles

  • Euglycemic Diabetic Ketoacidosis Symptoms

    OBJECTIVE Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complication. RESEARCH DESIGN AND METHODS Cases identified incidentally are described. RESULTS We identified 13 episodes of SGLT-2 inhibitor–associated euDKA ...

    ketosis Apr 29, 2018
  • Euglycemic Diabetic Ketoacidosis Treatment

    SESSION TITLE: Critical Care Student/Resident Case Report Posters I SESSION TYPE: Student/Resident Case Report Poster INTRODUCTION: A 47 year-old woman with type 1 diabetes presented with euglycemic diabetic ketoacidosis (DKA) that initially went undiagnosed. Recognition and treatment with insulin resulted in rapid resolution of her clinical condition. CASE PRESENTATION: A 47 year-old woman presented to our hospital with four days of fever, abdom ...

    ketosis Apr 7, 2018
  • Euglycemic Dka Mechanism

    Diabetic Ketoacidosis With SGLT2 Inhibitors Is Manageable The euglycemic diabetic ketoacidosis (DKA) that has recently been associated with the use of sodiumglucose cotransporter 2 (SGLT2) inhibitors will probably turn out to be very infrequent in patients with type 2 diabetes and "predictable, detectable, and preventable" in those with type 1 diabetes, two leading clinical trialists assert in a new editorial published in the September issue of ...

    ketosis Apr 29, 2018
  • Euglycemic Ketoacidosis Definition

    Go to: A 34-year-old man with a 19-year history of type 1 diabetes presented as an emergency with a 4-day history of nausea, vomiting, and flu-like symptoms. He was on a basal bolus insulin regime comprising 8 units of bolus insulin lispro injected at mealtimes and 12 units of basal isophane insulin at bedtime, but did not monitor capillary blood glucose levels. He did however empirically increase his insulin doses during times of illness and had ...

    ketosis Apr 25, 2018
  • What Is Euglycemic Diabetic Ketoacidosis?

    Correspondence Address: Monish S Raut Department of Cardiac Anesthesiology, Sir Ganga Ram Hospital, New Delhi - 110 060 India Source of Support: None, Conflict of Interest: None DOI: 10.4103/ija.IJA_359_17 How to cite this article: Raut MS, Maheshwari A. Euglycemic diabetic ketoacidosis by sodium glucose co-transporter inhibitors: Real but preventable concern. Indian J Anaesth 2017;61:524 Sir, We are thankful for the comments on 'Sodium glucose c ...

    diabetes Jan 4, 2018
  • Euglycemic Ketoacidosis Mechanism

    You’ve become the New York Times and the Wall Street Journal of medicine. A must-read every morning. ” ...

    ketosis Apr 27, 2018

More in ketosis